Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic Transplantation: Beta Cell Replacement.

David L. Bigam1, AM James Shapiro

  • 1University of Alberta Hospital, 8440-112 Street NW, Edmonton, Alberta, T6G 2B7, Canada.

Current Treatment Options in Gastroenterology
|September 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Clavien-Dindo classification and comprehensive complication index in patients undergoing simultaneous pancreas-kidney transplantation.

World journal of transplantation·2025
Same author

Human research islet cell culture outcomes at the Alberta Diabetes Institute IsletCore.

Islets·2024
Same author

Routine utilization of machine perfusion in liver transplantation: Ready for prime time?

World journal of gastroenterology·2024
Same author

Rate of prophylactic anti-Xa achievement and impact on venous thromboembolism following oncologic hepato-pancreatico-biliary surgery: A prospective cohort study.

American journal of surgery·2022
Same author

Reassessment of the embryonic fusion plane between the ventral and dorsal pancreases in human donors for transplantation.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2022
Same author

Addressing organ shortages: progress in donation after circulatory death for liver transplantation

Canadian journal of surgery. Journal canadien de chirurgie·2020

Pancreatic transplantation, or beta cell replacement, can improve survival and quality of life for diabetic patients. This procedure helps manage blood sugar, potentially reversing diabetes complications and enhancing outcomes, especially when combined with a kidney transplant.

Area of Science:

  • Endocrinology
  • Transplantation immunology
  • Nephrology

Background:

  • Diabetes mellitus is a major global health burden, causing significant morbidity and mortality.
  • Diabetic complications like nephropathy, retinopathy, and cardiovascular disease severely impact patient survival and quality of life.
  • Current treatments often fail to fully manage hyperglycemia and prevent long-term sequelae.

Purpose of the Study:

  • To review the indications and contraindications for pancreas transplantation (whole organ or islet cell).
  • To discuss peri-procedure care and the short- and long-term prognosis following pancreas transplantation.
  • To highlight the benefits of beta cell replacement in managing diabetes and its complications.

Main Methods:

  • Literature review of pancreatic transplantation outcomes.

Related Experiment Videos

  • Analysis of patient selection criteria for whole organ versus islet cell transplantation.
  • Synthesis of data on peri-transplant management and long-term follow-up.
  • Main Results:

    • Pancreas transplantation can restore euglycemia, stabilizing or reversing diabetic complications.
    • Combined pancreas-kidney transplantation demonstrates improved survival rates in diabetic patients.
    • Beta cell replacement, encompassing both whole organ and islet transplantation, offers significant therapeutic potential.

    Conclusions:

    • Pancreas transplantation is a viable option for select patients with type 1 diabetes, particularly those with labile control or complications.
    • Restoring euglycemia through beta cell replacement can lead to improved quality of life and potentially better long-term outcomes.
    • Further research and standardized protocols are essential for optimizing pancreas transplantation outcomes.